No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs118114821 |
chr3:116086813-116086814 |
Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs541780372 |
chr3:116086855-116086856 |
Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs149529520 |
chr3:116086883-116086884 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs188494399 |
chr3:116086923-116086924 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs533612219 |
chr3:116086924-116086925 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs545261865 |
chr3:116086926-116086927 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs563814755 |
chr3:116086990-116086991 |
Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs181258308 |
chr3:116086991-116086992 |
Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs185744601 |
chr3:116087029-116087030 |
Enhancers Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs1054632 |
chr3:116087069-116087070 |
Enhancers Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs139947155 |
chr3:116087104-116087105 |
Enhancers Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs201150548 |
chr3:116087109-116087110 |
Enhancers Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs547319569 |
chr3:116087110-116087111 |
Enhancers Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs4831095 |
chr3:116087170-116087171 |
Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs539627368 |
chr3:116087181-116087182 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs59119132 |
chr3:116087245-116087246 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs200613553 |
chr3:116087253-116087254 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs569751282 |
chr3:116087254-116087255 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs190503871 |
chr3:116087267-116087268 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs571470382 |
chr3:116087395-116087396 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs536711274 |
chr3:116087405-116087406 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs149246738 |
chr3:116087414-116087415 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs112276098 |
chr3:116087440-116087441 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs541022893 |
chr3:116087441-116087442 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs527587860 |
chr3:116087469-116087470 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs16824815 |
chr3:116087492-116087493 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs370730419 |
chr3:116087505-116087506 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs374359902 |
chr3:116087513-116087514 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs537887763 |
chr3:116087566-116087567 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs578240049 |
chr3:116087574-116087575 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs80000130 |
chr3:116087579-116087580 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs563702662 |
chr3:116087750-116087751 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs531050277 |
chr3:116087839-116087840 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs542791719 |
chr3:116087882-116087883 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs561027911 |
chr3:116087911-116087912 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs528514117 |
chr3:116087935-116087936 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs183885268 |
chr3:116087936-116087937 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs372348780 |
chr3:116087942-116087943 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs114073322 |
chr3:116087951-116087952 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs199556276 |
chr3:116087983-116087984 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs77891777 |
chr3:116087992-116087993 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs567649693 |
chr3:116087998-116087999 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs187148625 |
chr3:116088019-116088020 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs142550923 |
chr3:116088047-116088048 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs5852008 |
chr3:116088070-116088071 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs537228830 |
chr3:116088082-116088083 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs13323946 |
chr3:116088116-116088117 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
48 |
rs147728767 |
chr3:116088121-116088122 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs140913711 |
chr3:116088128-116088129 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs724115 |
chr3:116088165-116088166 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|